BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adebisi AO, Conway BR. Modification of drug delivery to improve antibiotic targeting to the stomach. Ther Deliv 2015;6:741-62. [PMID: 26149788 DOI: 10.4155/tde.15.35] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ispas-szabo P, De Koninck P, Calinescu C, Mateescu MA. Carboxymethyl Starch Excipients for Drug Chronodelivery. AAPS PharmSciTech 2017;18:1673-82. [DOI: 10.1208/s12249-016-0634-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
2 de Souza MPC, de Camargo BAF, Spósito L, Fortunato GC, Carvalho GC, Marena GD, Meneguin AB, Bauab TM, Chorilli M. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections. Crit Rev Microbiol 2021;47:435-60. [PMID: 33725462 DOI: 10.1080/1040841X.2021.1895721] [Reference Citation Analysis]
3 Mauri E, Naso D, Rossetti A, Borghi E, Ottaviano E, Griffini G, Masi M, Sacchetti A, Rossi F. Design of polymer-based antimicrobial hydrogels through physico-chemical transition. Mater Sci Eng C Mater Biol Appl 2019;103:109791. [PMID: 31349504 DOI: 10.1016/j.msec.2019.109791] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
4 Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release 2016;240:504-26. [PMID: 27292178 DOI: 10.1016/j.jconrel.2016.06.016] [Cited by in Crossref: 184] [Cited by in F6Publishing: 154] [Article Influence: 30.7] [Reference Citation Analysis]
5 Villegas I, Rosillo MÁ, Alarcón-de-la-Lastra C, Vázquez-Román V, Llorente M, Sánchez S, Gil AG, Alcalde P, González E, Rosell E, Nieto C, Fernandez-Campos F. Amoxicillin and Clarithromycin Mucoadhesive Delivery System for Helicobacter pylori Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy. Pharmaceutics 2021;13:153. [PMID: 33498958 DOI: 10.3390/pharmaceutics13020153] [Reference Citation Analysis]
6 Lotfipour F, Shahi S, Farjami A, Salatin S, Mahmoudian M, Dizaj SM. Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route. Biomed Res Int 2021;2021:9322282. [PMID: 34746313 DOI: 10.1155/2021/9322282] [Reference Citation Analysis]